MIRM

Mirum Pharmaceuticals, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$94.17

Market Cap

$4.73B

Beta

0.52

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+54.74%

EPS Growth (YoY)+73.57%

Revenue CAGR 3Y+89.13%

P/E Ratio0.0

PEG Ratio—

FCF Yield+1.16%

Debt / Equity1.02

Interest Coverage-1.5x

No credit card required

Already have an account? Sign in to view the full analysis for MIRM.